These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38069135)

  • 1. Lovastatin Treatment Inducing Apoptosis in Human Pancreatic Cancer Cells by Inhibiting Cholesterol Rafts in Plasma Membrane and Mitochondria.
    Gyoten M; Luo Y; Fujiwara-Tani R; Mori S; Ogata R; Kishi S; Kuniyasu H
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
    Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
    J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Irwin ME; Mueller KL; Bohin N; Ge Y; Boerner JL
    J Cell Physiol; 2011 Sep; 226(9):2316-28. PubMed ID: 21660955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt.
    Park EK; Lee EJ; Lee SH; Koo KH; Sung JY; Hwang EH; Park JH; Kim CW; Jeong KC; Park BK; Kim YN
    Br J Pharmacol; 2010 Jul; 160(5):1212-23. PubMed ID: 20590613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells.
    Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X
    Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents.
    Li YC; Park MJ; Ye SK; Kim CW; Kim YN
    Am J Pathol; 2006 Apr; 168(4):1107-18; quiz 1404-5. PubMed ID: 16565487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.
    Gupta VK; Sharma NS; Kesh K; Dauer P; Nomura A; Giri B; Dudeja V; Banerjee S; Bhattacharya S; Saluja A; Banerjee S
    Cancer Lett; 2018 Dec; 439():101-112. PubMed ID: 30290209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism.
    Fujiwara-Tani R; Sasaki T; Takagi T; Mori S; Kishi S; Nishiguchi Y; Ohmori H; Fujii K; Kuniyasu H
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic trioxide sensitizes pancreatic cancer cells to gemcitabine through downregulation of the TIMP1/PI3K/AKT/mTOR axis.
    Tian Z; Tan Y; Lin X; Su M; Pan L; Lin L; Ou G; Chen Y
    Transl Res; 2023 May; 255():66-76. PubMed ID: 36400307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines.
    Masuo H; Kubota K; Shimizu A; Notake T; Miyazaki S; Yoshizawa T; Sakai H; Hayashi H; Soejima Y
    Cancer Sci; 2023 Nov; 114(11):4388-4400. PubMed ID: 37700464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
    Liu DL; Bu HQ; Jin HM; Zhao JF; Li Y; Huang H
    Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins.
    Herrero-Martin G; López-Rivas A
    FEBS Lett; 2008 Jul; 582(17):2589-94. PubMed ID: 18582466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer.
    Venkatasubbarao K; Peterson L; Zhao S; Hill P; Cao L; Zhou Q; Nawrocki ST; Freeman JW
    Mol Cancer; 2013 Sep; 12(1):104. PubMed ID: 24025152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
    Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
    Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
    Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
    Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B; Christgen M; Kurdow R; Haye S; Kremer B; Kalthoff H; Ungefroren H
    Int J Cancer; 2004 Mar; 109(2):182-8. PubMed ID: 14750167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.
    Lu C; Yang D; Sabbatini ME; Colby AH; Grinstaff MW; Oberlies NH; Pearce C; Liu K
    BMC Cancer; 2018 Feb; 18(1):149. PubMed ID: 29409480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium transporter protein solute carrier family 41 member 1 suppresses human pancreatic ductal adenocarcinoma through magnesium-dependent Akt/mTOR inhibition and bax-associated mitochondrial apoptosis.
    Xie J; Cheng CS; Zhu XY; Shen YH; Song LB; Chen H; Chen Z; Liu LM; Meng ZQ
    Aging (Albany NY); 2019 May; 11(9):2681-2698. PubMed ID: 31076559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
    Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
    Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.